Product Overview

As a healthcare provider, you are focused on finding the most effective treatment, based on each patient’s response. GE Healthcare is providing you the tools to help make this goal a reality with the Discovery* PET/CT 710 and Q.Suite1. The entirely new PET/CT scanner and breakthrough tools for quantitative PET assist you in making appropriate treatment decision for individual patients.

1. Discovery PET/CT 710, and the components of Q.Suite, are not CE marked and cannot be placed on the market or put into service in the relevant countries until all required regulatory approvals have been obtained. Not available for sale in all markets.

Benefits

Breakthrough tools for quantitative PET

With so much potential for variation, each part of the workflow must be addressed for quantitative PET to be effective. With Q.Suite1, new capabilities from GE Healthcare work together to drive quantitative consistency.

Q.Suite can help physcians assess therapy response early and effectively, allowing oncologists to modify treatment strategies without waiting for physical results.  Effective therapy may help improve the patient’s quality of life and overall outcome as well as reduce the cost burden of ineffective treatment.

Daily quality control

  • Count-Rate independent performance: Great performance at any count rate.
  • Real-Time Temperature Compensation: Consistent performance. Every exam. Every temperature.

Workflow

  • Q.Core: Accelearting your quantitative imaging workflow.
  • Q.Check: A quality control link between the scanner and the workstation.

Motion correction

  • Q.Static: Reducing open motion effects quickly and simply.

Reconstruction algorithm

  • Q.AC: Attenuation consistency for demanding protocols such as Cine CTAC.

Analysis and reporting applications

  • PET VCAR: Powerful patient evaluation and monitoring. PET VCAR can do evaluations based on PERCIST and RECIST and incorporates Q.Check.

1. Discovery PET/CT 710, and the components of Q.Suite, are not CE marked and cannot be placed on the market or put into service in the relevant countries until all required regulatory approvals have been obtained. Not available for sale in all markets.

Technology

The Discovery PET/CT 710 offers tried and true technologies:

  • Innovations with a 40-mm detector at 0.35-sec rotation speed.
  • Up to 60% lower CO2 emissions using the energy saving mode.
  • Advanced applications to help clinicians make a fast and confident diagnosis.
  • ASiR1 technology may allow for reduced mA in the acquisition of diagnostic images.
  • Simplified workflow for quick and streamlined operation.
  • Scalable, modular design for ease of service.
  • 128-slice axial overlapped reconstruction for improved Z-axis visualization compared to non-overlapped reconstruction.    

Q.Suite2 is the product of close, ongoing partnerships between technology leaders and clinical researchers.  We learned about the challenges of quantitative PET from our customers and developed Q.Suite with their help.  Q.Suite is built on a platform that can support ongoing development in the future.  It will constitute an important step forward in capturing consistent quantitative measurements.

Learn more about Q.Suite.

1. In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.

2. Discovery PET/CT 710, and the components of Q.Suite, are not CE marked and cannot be placed on the market or put into service in the relevant countries until all required regulatory approvals have been obtained. Not available for sale in all markets.

Q Suite

Introducing Q.Suite

It's all about finding the most effective treatment sooner, based on each patient's response. It's the future of PET/CT. And the tools within Q.Suite1 are designed to help make it a reality.

Together with our customers, we are focused on improving cost, quality, and access in PET imaging — a smarter path to tomorrow's care.

personalized care
 
personalized care
 
suite button
 

 

Discovery PET/CT 710, Discovery PET/CT 610 , and the components of Q.Suite, are not approved by the regulatory bodies of Brazil, Costa Rica, Peru, Argentina, Uruguay, Mexico, Colombia and Venezuela and therefore cannot be sold/imported until regulatory approval is obtained.

A smarter path

Videos

One image. All the counts. Motion eliminated.
We’re designing Q.Freeze1 to combine the quantitative benefits of 4D phase-matched PET/CT imaging into a single static image.  By collecting CT and PET data at each phase of the breathing cycle, then matching the data for attenuation consistency.  None of the acquisition data is wasted, as 100% of the counts collected are combined to create a single static image.  The goal – a resulting image that has the dual benefit of frozen patient motion and reduced image noise.

1. Q.Freeze is not CE marked and cannot be placed on the market or put into service until all required regulatory approvals have been obtained. Not available for sale in all markets.

 

Reducing organ motion effects, quickly and simply.
Q.Static2 represents a starting point for adding basic motion correction techniques to your facility and the opportunity to build towards a full 4D phase-matched workflow.  Without disrupting your standard static whole-body workflow, were designing Q.Static to automatically isolate date when organs are in a low motion state, thereby correcting for motion across the entire chest or torso.  The result is a single image series with reduced blurring from organ motion, and therefore more consistent quantitation compared to a static image.

2. Q.Static is not CE marked and cannot be placed on the market or put into service until all required regulatory approvals have been obtained. Not available for sale in all markets.